Copy Link Print Information

Drozitumab

(Synonyms: PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody)
Customer Review

Based on 1 Customer Validation

Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma.

For research use only. We do not sell to patients.

  • Purity: 99.00%
  • CAS No.: 912628-39-8
  • Molecular Weight:143.06 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Drozitumab
  • Experimental Validation Results for Drozitumab
  • Experimental Validation Results for Drozitumab
  • Drozitumab Chemical Structure
    Drozitumab Chemical Structure
CAS No.: 912628-39-8
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Drozitumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 lambda

  • 1/16

    Flow cytometric analysis of 1.5X106 HEPG2 cells with Drozitumab (HY-P99286, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 lambda, Isotype Control (HY-P99992, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Loaded Drozitumab on AHC2 biosensor, can bind TRAIL R2/TNFRSF10B Protein, Human (Biotinylated, HEK293, His-Avi, HY-P78220) with an affinity constant of 1.051E-08 M as determined in BLI assay.

  • Drozitumab Chemical Structure
    1/16
  • Drozitumab
  • Flow cytometric analysis of 1.5X106 HEPG2 cells with Drozitumab (HY-P99286, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 lambda, Isotype Control (HY-P99992, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Loaded Drozitumab on AHC2 biosensor, can bind TRAIL R2/TNFRSF10B Protein, Human (Biotinylated, HEK293, His-Avi, HY-P78220) with an affinity constant of 1.051E-08 M as determined in BLI assay.